JPS60188398A - Production of 6beta-fluoro-delta1,4-pregnadiene derivative - Google Patents

Production of 6beta-fluoro-delta1,4-pregnadiene derivative

Info

Publication number
JPS60188398A
JPS60188398A JP4528584A JP4528584A JPS60188398A JP S60188398 A JPS60188398 A JP S60188398A JP 4528584 A JP4528584 A JP 4528584A JP 4528584 A JP4528584 A JP 4528584A JP S60188398 A JPS60188398 A JP S60188398A
Authority
JP
Japan
Prior art keywords
fluorine
fluoro
reaction
derivative
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4528584A
Other languages
Japanese (ja)
Inventor
Takao Takahara
高原 孝郎
Kazuhiro Shimokawa
下川 和弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikin Industries Ltd
Original Assignee
Daikin Industries Ltd
Daikin Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Industries Ltd, Daikin Kogyo Co Ltd filed Critical Daikin Industries Ltd
Priority to JP4528584A priority Critical patent/JPS60188398A/en
Publication of JPS60188398A publication Critical patent/JPS60188398A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To produce the titled fluorine-containing steroid compound useful as an anti-inflammatory agent, in high yield, by reacting an alkali metal salt of an organic acid with fluorine gas, reacting the product with DELTA<3.5>-pregnadiene derivative, and separating the objective product from the reaction product. CONSTITUTION:An organic acid alkali metal salt (e.g. CH3COONa) is made to react with fluorine gas (usually diluted to <=20mol% with an inert gas such as N2) preferably in a chlorofluorocarbon solvent at about -75 deg.C. The obtained reaction mixture is made to react with a DELTA<3.5>-pregnadiene derivative, and the objective compound is separated from the product by column chromatography, high-performance liquid chromatography, etc.

Description

【発明の詳細な説明】 本発明は、含フツ素ステロイド化合物の製法に関する。[Detailed description of the invention] The present invention relates to a method for producing a fluorine-containing steroid compound.

含フツ素ステロイド化合物、特に副腎皮質ホルモンへフ
ッ素を導入した化合物は、すぐれた抗炎症作用を有して
いることが知られている。
It is known that fluorine-containing steroid compounds, particularly compounds in which fluorine is introduced into adrenal cortical hormones, have excellent anti-inflammatory effects.

この含フツ素ステロイド化合物(含フツ素副腎皮質ホル
モン)の一般的な製法は、ステロイド化合物とフッ素化
剤を反応させることからなり、フッ素を導入できる位置
は、2.4.6.9.15および/または9β位にフッ
素を導入すると著I7い抗炎症作用の増強が見られる。
The general manufacturing method of this fluorine-containing steroid compound (fluorine-containing adrenal cortical hormone) consists of reacting the steroid compound with a fluorinating agent, and the positions where fluorine can be introduced are 2.4.6.9.15 When fluorine is introduced into the 9β-position and/or the 9β-position, a marked enhancement of the anti-inflammatory effect is observed.

また、これらステロイ用を抑制でき、すぐれた抗炎症剤
としてリウマチ等の治療に利用することができる。
In addition, it can suppress the use of these steroids, and can be used as an excellent anti-inflammatory agent to treat rheumatism and the like.

、々お、ステロイド化合物の位置番号の表示は、次のと
おりである。
, etc. The position numbers of steroid compounds are indicated as follows.

また、例えばその6位にフッ素が導入された化合物の異
性体は F F (6β位) (6β位) のように表示する。
Further, for example, an isomer of a compound in which fluorine is introduced at the 6th position is expressed as F F (6β position) (6β position).

従来、ステロイド化合物をフッ素化する際に用いられる
フッ素化剤と1〜て、F2、XeF2、FCIOs、C
Fs OF、CFsCOOF等が知られている。しかし
ながら、これらフッ素化剤のいずれを用いてステロイド
化合物のフッ素化を試みても、含フツ素ステロイド化合
物の収率は低いものである。
Conventionally, fluorinating agents used when fluorinating steroid compounds include F2, XeF2, FCIOs, C
FsOF, CFsCOOF, etc. are known. However, no matter which of these fluorinating agents is used to fluorinate steroid compounds, the yield of fluorine-containing steroid compounds is low.

最近、CTh C00F (酢酸存在下CH,+ CO
ONaにF2を作用させると発生するとされている。)
々るフッ素化剤が開発され含フッ素芳番族化合物あるい
は含フツ素糖類の合成に成功している。その反EHp に代表され、一般に前者の芳香環では水素とフッ素が置
換し、後者の糖類の2重結合ではその両端にフッ素およ
びアセトキシル基がそれぞれ付加するものである。
Recently, CTh C00F (CH, + CO in the presence of acetic acid
It is said that this occurs when F2 is applied to ONa. )
Several fluorinating agents have been developed, and fluorinated aromatic compounds or fluorinated sugars have been successfully synthesized. Typically, the aromatic ring of the former is substituted with hydrogen and fluorine, while the double bond of the latter saccharide has fluorine and acetoxyl groups added to both ends, respectively.

そこで本発明者らは、さらに該CHs C00Fをステ
ロイド化合物のフッ素化反応に利用すべく鋭意研究を進
めたところ、驚くべきことにステロイド化合物のフッ素
化反応機構は、前記反応(1)および(2)の反応機構
とは全く異ったものであり、予惣外の含フツ素ステロイ
ド化合物が収率よく生成することを姑い出[7本発明を
児成するに到った。
Therefore, the present inventors further conducted intensive research to utilize the CHs C00F in the fluorination reaction of steroid compounds, and surprisingly found that the fluorination reaction mechanism of steroid compounds was similar to reactions (1) and (2). ), the reaction mechanism was completely different from that of fluorine-containing steroid compounds, and the unexpected production of fluorine-containing steroid compounds in good yield was avoided [7] and the present invention was achieved.

すなわち、本発明の要旨は、有機酸のアルカリ金属塩と
フッ素ガスを反応させ、得られた反応混合物と△3?5
−プレグナジェン誘導体を反応させ、この反応混合物か
ら6β−フルオロ−△l+4−プレグナジェン誘導体を
分離することを特徴とする6β−フルオロ−△114−
プレグナジェン誘導体の製法に存する。
That is, the gist of the present invention is to react an alkali metal salt of an organic acid with fluorine gas, and to react with the resulting reaction mixture and △3?5.
- 6β-fluoro-Δ114- characterized in that a pregnagene derivative is reacted and a 6β-fluoro-Δ1+4-pregnagene derivative is separated from the reaction mixture.
The invention consists in a method for producing pregnagen derivatives.

本発明の反応を反応式で例示すると (式中、−はαおよびβ体の混合物、−−一は二重結合
が存在することもあることを示す。)のどときものであ
る。このステロイド化合物のフッ素化反応は、前記芳香
族化合物および糖類のフッ素化反応からは全く予想でき
ないもので、上記の反応式に見られるごとく6位にフッ
素が付加しAおよびB環の電子配置が変化し3位のアセ
トキシル基がオキソ基に変換され、6αおよび6β−フ
ルオロ−△4−プレグナン誘導体ならびに6β−フルオ
ロ−△114−プレグナジェン誘導体が同時に生成する
というものである。
The reaction of the present invention is illustrated by a reaction formula (in the formula, - indicates a mixture of α and β forms, and -1 indicates that a double bond may be present). This fluorination reaction of steroid compounds is completely unexpected from the fluorination reactions of aromatic compounds and sugars, and as seen in the above reaction formula, fluorine is added to the 6-position and the electronic configuration of the A and B rings is changed. The acetoxyl group at the 3-position is converted to an oxo group, and 6α and 6β-fluoro-Δ4-pregnane derivatives and 6β-fluoro-Δ114-pregnagene derivatives are simultaneously produced.

本発明の製法は、上記反応で得られた混合物から6β−
フルオロ△1ツ4−プレグナジェン訪導体を分離する工
程をさらに包含する。分離方法としては、通常のカラム
クロマトグラフィーや高速液体クロマトグラフィーが利
用される。
The production method of the present invention involves the production of 6β-
The method further includes the step of separating the fluoroΔ14-pregnagene visiting conductor. As a separation method, ordinary column chromatography or high performance liquid chromatography is used.

本発明でいう有機酸のアルカリ金属塩とは、低級カルボ
ン酸のアルカリ金属塩のことで、例えばCH3COON
a 、 CH3C)h COONa 1CH3CH2C
H2COONa等が挙げられ、Na塩に対応するK[も
好ましく用いられる。
The alkali metal salt of an organic acid in the present invention refers to an alkali metal salt of a lower carboxylic acid, such as CH3COON.
a , CH3C)h COONa 1CH3CH2C
Examples include H2COONa, and K corresponding to Na salt is also preferably used.

本発明の反応を実施する際用いられるフッ素ガスは、通
常N2またはHe等の不活性ガスで希釈されており一般
に20モル%以下の濃度で用いられも本発明の反応は、
通常フッ素に不活性々中性まだは弱酸性溶媒を用いて行
なわれ好ましくはクロロフルオロカーボン系溶媒および
/−!たけ有機酸の混合溶媒中で行なわれる。クロロフ
ルオロカーボン系溶媒は、反応温度(−75’C前後)
で液体であればよく、例えば、CC13F(フロン−1
1)、6一 CCJ2F+(7Elノン−2)、CBrF3(フロン
−13[3])、CHCez F(7o 7−21 )
、cncfp2()oン−22’)、CC/JFz C
ClF2 (フロン−114)、CB r Fz CB
 r F *(フロン−11482)等が挙げられる。
The fluorine gas used in the reaction of the present invention is usually diluted with an inert gas such as N2 or He, and is generally used at a concentration of 20 mol% or less.
This is usually carried out using a neutral or weakly acidic solvent inert to fluorine, preferably a chlorofluorocarbon solvent and/-! It is carried out in a mixed solvent of bamboo organic acids. The reaction temperature of the chlorofluorocarbon solvent (around -75'C)
For example, CC13F (Freon-1
1), 6-CCJ2F+ (7El non-2), CBrF3 (Freon-13 [3]), CHCez F (7o 7-21)
, cncfp2()on-22'), CC/JFz C
ClF2 (Freon-114), CB r Fz CB
Examples include rF* (Freon-11482).

また、有機酸は、低級カルボン酸であり、例えばCH3
Coot(。
Further, the organic acid is a lower carboxylic acid, for example, CH3
Coot(.

CH3CI(2C00H1CHx CJT2 CH2C
00II等が挙げられる。
CH3CI(2C00H1CHx CJT2 CH2C
00II and the like.

本発明の反応でフッ素化されるステロイド化合物は、弐
“ ON/ゝOR+ (上記式中、R1,R2およびR3は水素まだは低級ア
シル基を示す。) 等で表わされる△3+I−プレグナジェン誘導体である
がこれ(らに限定されない。
The steroid compound to be fluorinated in the reaction of the present invention is a △3+I-pregnagene derivative represented by 2"ON/ゝOR+ (in the above formula, R1, R2 and R3 are hydrogen or a lower acyl group). However, it is not limited to these (and others).

本発明の反応で生成するフルオロステロ・rド化F F (上記式中、R1、R2、R3、−および−−−−は前
記と同じ。) 等で表わされる化合物であり、本発明の製法で得られる
化合物は、ト記フルオロステロイド化合物のうちの6β
−フルオロ−△114−プレグナジェン誘導体である。
It is a compound represented by fluorostero-r-doped F F (in the above formula, R1, R2, R3, - and ---- are the same as above), etc. produced by the reaction of the present invention, and the production method of the present invention The compound obtained is 6β of the fluorosteroid compounds listed above.
-Fluoro-Δ114-pregnagene derivative.

前記原料ステロイド化合物のなかには固体のままで溶媒
に添加すると溶解し難いものがあるので、必要に応じC
CL、C)IC71s、C)12 C/! x等7.7
素化反応に不活性な溶媒に予め溶解させておき、この溶
液を反応溶媒に添加し反応に供することもできる。
Some of the above-mentioned raw material steroid compounds are difficult to dissolve when added to a solvent in a solid state, so C may be added as necessary.
CL, C) IC71s, C) 12 C/! x etc. 7.7
It is also possible to dissolve the compound in advance in a solvent inert to the hydrogenation reaction, and then add this solution to the reaction solvent for use in the reaction.

1時間以内である。Within 1 hour.

次に実施例および比較例を示し本発明を具体的に説明す
る。
Next, the present invention will be specifically explained with reference to Examples and Comparative Examples.

実施例 200 mlのポリエチレン容器にCCl5F(フロン
−11) 100 tnlSCHs COOH4mlお
よびCHs C00Na(微粉末) 600 ”f (
7,3m mol )を入れ激しく攪拌しながらドライ
アイス−アセトンで外部から冷却し、前記フラスコの液
中にN2ガスで10モル%に希釈したF2ガス(12m
 mol )を1分間1−00+++/の流速で30分
間通じた。次いで10コのCH2Cl2に溶解させた後
記の表に示すステロイド化合物(1) 930 W(2
,5mmol )を前記フラスコ内に添加し、−75°
Cで10分間攪拌反応させた。その後、フラスコ内に飽
和Na25Oa水溶液(1,5#+t)を加え反応を停
止し饗キ螢 30 mlのCHzCltで3同右 物 出混合物の溶
媒をエバポレータで除去し得られた固体をシリカゲルカ
ラムクロマトグラフィー(和光ゲルC−200゜3cM
〆x20m、溶媒:塩化メチレン/アセト;トリル−9
/1、ただし容量)に供し、分画液のうちシリカゲル薄
層クロマトグラフィー(前記と同じ。)で展開してR,
=0.43にスポットを生じるも10− のを集め、溶媒を減圧にして除去し、白色結晶531ダ
を得た。次にこの白色結晶のうちの100qを1ttt
lのメタノールに溶解させ、得られた溶液を高速液体ク
ロマトグラフィー(ウォーターズ社製 モデル510、
カラム:ラジアルパックc−18、溶出液:メタノール
/水−8/2、ただl、′#量、流出−N : 0.9
 M//分、検出波長: 25411 m )にかけ、
Rf= 12.7分〔化合物(’IT−a)と)?f=
10.5分〔化合物(11’−b)〕にピークを示す化
合物をそれぞれ分取12、核磁気共鳴(NMR)分析を
行った。なお、上記固化合物のピーク面積化け(IT 
−2)/(TI−b )−4/2であった。
Example 2 In a 00 ml polyethylene container, 4 ml of CCl5F (Freon-11) 100 tnlSCHs COOH and 600 ”f of CHs CO0Na (fine powder) were added.
F2 gas (12 mmol) diluted to 10 mol% with N2 gas was added to the liquid in the flask and cooled externally with dry ice-acetone while stirring vigorously.
mol) was passed for 30 minutes at a flow rate of 1-00+++/minute. Next, steroid compound (1) 930 W (2
, 5 mmol) into the flask and heated to -75°.
The mixture was stirred and reacted at C for 10 minutes. After that, a saturated Na25Oa aqueous solution (1,5#+t) was added to the flask to stop the reaction, and the solvent was removed using an evaporator and the resulting solid was subjected to silica gel column chromatography. (Wako Gel C-200°3cM
〆x20m, solvent: methylene chloride/acetate; tolyl-9
/1, but by volume), and the fractionated solution was developed with silica gel thin layer chromatography (same as above) to obtain R,
Although a spot was generated at =0.43, 10-10% was collected and the solvent was removed under reduced pressure to obtain 531 da of white crystals. Next, 100q of this white crystal is 1ttt
The resulting solution was subjected to high performance liquid chromatography (Waters Model 510,
Column: Radial Pack C-18, Eluent: Methanol/Water-8/2, only 1, '# amount, Effluent-N: 0.9
M//min, detection wavelength: 25411 m),
Rf = 12.7 minutes [with compound ('IT-a)]? f=
Compounds showing a peak at 10.5 minutes [compound (11'-b)] were each fractionated 12 and subjected to nuclear magnetic resonance (NMR) analysis. In addition, the peak area change (IT
-2)/(TI-b)-4/2.

NMR分析結果を次に示す。The NMR analysis results are shown below.

一化合物(T−a)− ’H−NMR(溶媒:CDC/s、内部標準:テトラメ
チルシラン) 上記表中、6α体および6α体は、それぞれ6α−フル
オロ体および6β−フルオロ体を示す。以下同意義。
One Compound (T-a)-'H-NMR (Solvent: CDC/s, Internal Standard: Tetramethylsilane) In the above table, 6α-form and 6α-form represent 6α-fluoro form and 6β-fluoro form, respectively. Same meaning below.

19F−NMR(溶媒:Cr)(J13、内部標準、ペ
ンシトリフルオライド) +11pのシグナル強度より6α体/6β体中1/2で
あった。
19F-NMR (solvent: Cr) (J13, internal standard, pencitrifluoride) The signal intensity of +11p was 1/2 of 6α form/6β form.

(弁大工今台 )k頁に〜乾くン 一化合物(U−b) LH−NMR(溶媒および内部標準は前記と同じ。)1
9F−NMR(溶媒および内部標準は前記と同じ。)1
4− 以上の分析結果より、化合物(II−3)および(T−
b)は、それぞハの後記の表に示す化合物であると同定
した。
(Bendaiku Imadai) On page K ~Drying compound (U-b) LH-NMR (Solvent and internal standard are the same as above.) 1
9F-NMR (Solvent and internal standard are the same as above.) 1
4- From the above analysis results, compounds (II-3) and (T-
b) were identified as the compounds shown in the table below in c.

比較例 実施例のCI(s COONaに代えてCF3Co0N
a 1/(7,4m mol ) を用いた他は、実施
例と同様の手順でフッ素化反応と生成物の牟離および分
析を行なった。結果を下表に示す。
Comparative Example CI (s COONa replaced by CF3Co0N)
The fluorination reaction, separation and analysis of the product were carried out in the same manner as in the example except that a 1/(7.4 mmol) was used. The results are shown in the table below.

0火丁余狗、ン欠真1ニー永2 昭和59年6月β日 特許庁長官 着 杉 和 夫 殿 1、事件の表示 昭和59年特許願第45285号2、
発明の名称 6β−フルオロ−Δ・4−プレグナジェン
誘導体の製法 3、補正をする者 事件との関係 特許出願人 住所 大阪市北区梅田1丁目12番39号新阪急ピル5
、補正の対象 明細書の「発明の詳細な説明」の欄 6、補正の内容 (別紙) ン訪導体である。
0 Kazuo Sugi, Director General of the Patent Office, June 1980, 1, Indication of the case, Patent Application No. 45285, filed in 1982, 2,
Title of the invention Process for producing 6β-fluoro-Δ・4-pregnagene derivative 3, Relationship to the case of the person making the amendment Patent applicant address New Hankyu Pill 5, 1-12-39 Umeda, Kita-ku, Osaka
, Subject of amendment Column 6 of "Detailed Description of the Invention" of the specification, Contents of amendment (attached sheet) A visiting conductor.

前記原料ステロイド化合物のなかには固体のままで溶媒
に添加すると溶解し難いものがあるので、必要に応じc
ce4%CHCら、CH2Cl3等フッ素化反応に不活
性な溶媒に予め溶解させでおき、この溶液を反応溶媒に
添加し反応に供することもできる。
Some of the above-mentioned raw material steroid compounds are difficult to dissolve when added to a solvent in a solid state, so c.
It is also possible to preliminarily dissolve ce4% CHC, CH2Cl3, etc. in a solvent inert to the fluorination reaction, and add this solution to the reaction solvent for use in the reaction.

本発明の反応の反応温度は、通常30−(00’0で好
ましくは0〜−80°Cが採用され、反応時間は普通1
時間以内である。
The reaction temperature of the reaction of the present invention is usually 30-(00'0, preferably 0 to -80°C, and the reaction time is usually 1
Within hours.

次に実施例および比較例を示し本発明を具体的(以下余
白1次頁に続く) 2−
Next, Examples and Comparative Examples will be shown to illustrate the present invention (the following margin continues on the first page) 2-

Claims (1)

【特許請求の範囲】[Claims] 1、有機酸のアルカリ金属塩とフッ素ガスを反応させ、
得られた反応混合物とΔ2,6−プレグナジエン誘導体
を反応させ、この反応混合物から6β−フルオロ−△l
+4−グレグナジエン誘導体を分離することを特徴とす
る6β−フルオロ−△1,4−プレグナジェン誘導体の
製法。
1. Reacting an alkali metal salt of an organic acid with fluorine gas,
The obtained reaction mixture is reacted with a Δ2,6-pregnadiene derivative, and 6β-fluoro-Δl is produced from this reaction mixture.
A method for producing a 6β-fluoro-Δ1,4-pregnadiene derivative, which comprises separating a +4-gregnadiene derivative.
JP4528584A 1984-03-08 1984-03-08 Production of 6beta-fluoro-delta1,4-pregnadiene derivative Pending JPS60188398A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4528584A JPS60188398A (en) 1984-03-08 1984-03-08 Production of 6beta-fluoro-delta1,4-pregnadiene derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4528584A JPS60188398A (en) 1984-03-08 1984-03-08 Production of 6beta-fluoro-delta1,4-pregnadiene derivative

Publications (1)

Publication Number Publication Date
JPS60188398A true JPS60188398A (en) 1985-09-25

Family

ID=12715037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4528584A Pending JPS60188398A (en) 1984-03-08 1984-03-08 Production of 6beta-fluoro-delta1,4-pregnadiene derivative

Country Status (1)

Country Link
JP (1) JPS60188398A (en)

Similar Documents

Publication Publication Date Title
JPH02218642A (en) Prostaglandin
JPWO2019240143A1 (en) A method for producing a triazolindione adduct, a method for producing a triazolindione adduct, a method for producing an en compound, and a method for analyzing an en compound.
JPS60188398A (en) Production of 6beta-fluoro-delta1,4-pregnadiene derivative
JPS61218580A (en) 2-(2-amino-4-thiazolyl)-2-methoxyiminoacetic acid derivativeand manufacture
JPS5824595A (en) Steroid compound and manufacture
JP3429432B2 (en) Vitamin D derivative crystal and method for producing the same
JPH0341049A (en) Production of substituted 3-formyl-3-bute-1- noic acid
Osawa et al. Synthesis and conformation of 2β-hydroxytestosterone
AU640550B2 (en) Heterocyclic amido prostaglandin analogs
JP3171400B2 (en) Hydroxycarbonyl derivative and method for producing the same
JPS59110644A (en) Manufacture of cyclopentenone and novel acetylene ester
JPH02111747A (en) Preparation of carbon 13-marked 5-aminolevulinic acid and derivative thereof
JP2893906B2 (en) Method for producing unsaturated ketone compound
JP2501604B2 (en) Process for producing cholesta-1,4,6-trien-3-ones
JPH0733769A (en) Pyrazolopyridine derivative and its production
Ferraz et al. An Improved Synthesis of (±) Frullanolide. Application of Selenium Reagents
JPS61158942A (en) Production of cis-2-cycloalkene-1,4-diol
JPH06211780A (en) Benzoyl cyanide derivative, its production and reaction using the same
JPS59139398A (en) Production of fluorine-containing steroid
JPH026433A (en) Optically active fluorine-containing malonic acid ester derivative and production thereof
JPS60174769A (en) Novel 3-hydroxymethyl-2-phenylquinoline derivative
JPH07116219B2 (en) Method for producing compound having steroid skeleton
JPH03264547A (en) Production of long chain acyl derivatives of tartaric acid
JPH0131520B2 (en)
JPH02237963A (en) Tropolone derivative